Heparanase enhances myeloma progression via CXCL10 downregulation. - Wikidata - awgldk - TriplyDB

Heparanase enhances myeloma progression via CXCL10 downregulation.

Heparanase enhances myeloma progression via CXCL10 downregulation.

http://www.wikidata.org/entity/Q34289445

about

The Role of Chemokines in Shaping the Balance Between CD4(+) T Cell Subsets and Its Therapeutic Implications in Autoimmune and Cancer Diseases Heparanase Enhances Tumor Growth and Chemoresistance by Promoting Autophagy Heparanase 2 Attenuates Head and Neck Tumor Vascularity and Growth.Heparanase 2 expression inversely correlates with bladder carcinoma grade and stage.Heparanase is required for activation and function of macrophages.The prognostic significance of heparanase expression in metastatic melanoma The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics.Heparanase overexpression down-regulates syndecan-1 expression in a gallbladder carcinoma cell line.The Heparanase Inhibitor PG545 Attenuates Colon Cancer Initiation and Growth, Associating with Increased p21 Expression Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo.Monokine induced by interferon gamma (MIG/CXCL9) is an independent prognostic factor in newly diagnosed myeloma.Chemotherapy induces expression and release of heparanase leading to changes associated with an aggressive tumor phenotype.Neoplastic plasma cells generate an inflammatory environment within bone marrow and markedly alter the distribution of T cells between lymphoid compartments.Heparanase: From basic research to therapeutic applications in cancer and inflammation.CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy.Opposing Functions of Heparanase-1 and Heparanase-2 in Cancer Progression.Prognostic significance of heparanase expression in primary and metastatic breast carcinoma.Patient derived xenografts (PDX) predict an effective heparanase-based therapy for lung cancer.Cancer Cell Glycocalyx and Its Significance in Cancer Progression Polymorphisms in the heparanase gene in multiple myeloma association with bone morbidity and survival

P2860

Q26773127-17D9F8BF-1692-4EE3-A20A-4DB5DABB7103 Q36070533-74355302-453D-40E6-A949-BB2C2B7916F1 Q36917969-7E152B2B-A2CE-4DD1-AD38-DBDD808D94D6 Q37225598-3E319487-F00B-4C27-8FFC-BC9C4EB59DF2 Q37473740-6200ED39-A164-4C11-95E0-A2AEB7683C34 Q37688833-A702C564-D4B4-4EE9-B869-D48BAC99271D Q38238094-A9070D60-D637-41A2-80C8-1B0DEEAA029C Q38709903-61EC68FD-CCA7-497F-9F7A-3456F0530B87 Q38718475-BE16C4B6-375E-4D9D-B7A2-2C219071DBE7 Q38764048-B365D110-027E-4E4F-B244-17907AE6D6B1 Q39901834-A7D8F2BE-7CF5-4AF5-9629-D4F56AC667A5 Q41158870-8E5F931C-99F5-4687-9B6F-913DE52EA9C5 Q42244787-DFF08064-42B5-467E-AA1F-A4544158DEF1 Q42587945-4806761A-C793-45D4-B56A-A99886F79793 Q45931583-BAB80031-384A-4888-8E3F-A417E188B5DA Q47377873-FC86AE8E-3DFB-4BA2-90B9-471A29199116 Q49787551-F0E4AC74-37FB-4808-9F8F-1BD1B9397AC5 Q55054468-71277FE1-F161-4E51-8A0E-AF12F2CE31C7 Q57168005-A7D7FE51-8B2A-42C2-9E4E-6BC4E506A056 Q59245028-6067DE32-6F2F-4C52-A91F-686D7DEAB78E

P2860

Heparanase enhances myeloma progression via CXCL10 downregulation.

http://www.wikidata.org/entity/Q34289445

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

Heparanase enhances myeloma progression via CXCL10 downregulation.

@ast

Heparanase enhances myeloma progression via CXCL10 downregulation.

@en

Heparanase enhances myeloma progression via CXCL10 downregulation.

@nl

type

label

Heparanase enhances myeloma progression via CXCL10 downregulation.

@ast

Heparanase enhances myeloma progression via CXCL10 downregulation.

@en

Heparanase enhances myeloma progression via CXCL10 downregulation.

@nl

prefLabel

Heparanase enhances myeloma progression via CXCL10 downregulation.

@ast

Heparanase enhances myeloma progression via CXCL10 downregulation.

@en

Heparanase enhances myeloma progression via CXCL10 downregulation.

@nl

P1433

Q34289445-6EE9FBF6-2759-4E4B-B152-ACA29F1D96B4

P1476

Q34289445-C81D78FB-3297-480A-8FFE-500EF85C7265

P2093

Q34289445-58468F15-70EF-4359-8BE2-ECD83C9D5007

Q34289445-647C4EC1-A3F1-46DA-B3CB-C93397740351

Q34289445-8997C848-A3E6-402F-B303-AFCBC1577089

Q34289445-A48DCF0D-F38B-4891-B73C-38BDD5D05166

Q34289445-AAE6D672-7649-49EC-A8B8-7C5371BF441B

Q34289445-BF6AC7F4-F370-4B81-B7C2-4AD39B22D561

Q34289445-C85D0DEC-458F-4993-AFDA-B937B5723CB9

Q34289445-FDDA6855-F8F8-4140-9223-E83AB3162845

P2860

Q34289445-000EB7CC-6B74-434D-A143-4802D3D3E6FA

Q34289445-00EE61DE-1700-4FC2-A028-52FBF4105AC8

Q34289445-0FC63443-88F6-4603-B03A-D24F0C1F9B42

Q34289445-1B3FC6AA-32F7-4255-9818-EB936FA955EA

Q34289445-21FCA256-9FC1-45E3-BC86-8FB02C18F1C6

Q34289445-29DD3C65-B4DA-49E3-AFDD-1DFE9EB751A5

Q34289445-2A90627D-B865-42A6-8178-CFF43793D034

Q34289445-2D216597-91BB-42C9-B8FD-61F09F01D8A6

Q34289445-3177E40B-4CFF-4362-A1D6-3F8019C045F9

Q34289445-36900B6D-ABBD-4E63-9AF2-C1BA44C5AEBB

P2888

Q34289445-E1C58CB3-4B0D-4A43-BE3D-2846DB9C917A

P304

Q34289445-F732C7CA-E360-4D3D-A0C5-2FE285ED3866

P31

Q34289445-DE312FBD-E9D6-47CA-BCD4-488430F7D5AC

P356

Q34289445-E31A7EB7-72A0-4622-ABD8-3A3672C76D77

P433

Q34289445-3AED242C-4F3A-4185-B47A-0F54D8686FB7

P478

Q34289445-15640A93-7645-4FD5-A311-A11EA7D09FF4

P577

Q34289445-5D690A96-BA23-4B2C-972A-B9190316ED80

P6179

Q34289445-485681DC-B846-4991-A210-036AEB6795BB

P698

Q34289445-7B81773C-BC85-4763-8205-4AF503E35ED8

P932

Q34289445-0CB92792-65E4-498F-916D-EE74B9A3F2BD

P356

P1433

P1476

Heparanase enhances myeloma progression via CXCL10 downregulation.

@en

P2093

A Nagler

http://www.w3.org/2001/XMLSchema#string

G Wildbaum

http://www.w3.org/2001/XMLSchema#string

I Vlodavsky

http://www.w3.org/2001/XMLSchema#string

K Beider

http://www.w3.org/2001/XMLSchema#string

N Ilan

http://www.w3.org/2001/XMLSchema#string

N Karin

http://www.w3.org/2001/XMLSchema#string

U Barash

http://www.w3.org/2001/XMLSchema#string

Y Zohar

http://www.w3.org/2001/XMLSchema#string

P2860

Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation

IP-10 induces dissociation of newly formed blood vessels

Heparanase induces endothelial cell migration via protein kinase B/Akt activation

Control of autophagic cell death by caspase-10 in multiple myeloma

Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate

A novel human heparanase splice variant, T5, endowed with protumorigenic characteristics.

Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis.

Heparanase enhances local and systemic osteolysis in multiple myeloma by upregulating the expression and secretion of RANKL

Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis.

Clinical significance of heparanase splice variant (t5) in renal cell carcinoma: evaluation by a novel t5-specific monoclonal antibody

P2888

P304

2178-2187

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/LEU.2014.121

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1029024545

http://www.w3.org/2001/XMLSchema#string

P698

24699306

http://www.w3.org/2001/XMLSchema#string

P932

4185261

http://www.w3.org/2001/XMLSchema#string